Published in Nursing Home and Elder Business Week, December 3rd, 2006
Study 1: Research findings, "Alpha-tocopherol distribution in lipoproteins and anti-inflammatory effects differ between CHD-patients and healthy subjects," are discussed in a new report. According to a study from Leipzig, Germany, "The purpose of this study was to investigate the dose-dependent effects of RRR-alpha-tocopherol supplementation in coronary heart disease (CHD) patients and healthy subjects on plasma alpha-tocopherol levels, plasma lipoprotein distribution, LDL oxidation, and inflammatory plasma markers. 12 patients with coronary heart disease and 12 healthy subjects...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Nursing Home and Elder Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.